Ryuichi Hirayama

Has grant

Specially Appointed Assistant Professor

Osaka University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Medical Imaging Medical Imaging professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ryuichi Hirayama is a Specially Appointed Assistant Professor at Osaka University, Japan. His research primarily focuses on neuro-oncology and neurovascular conditions, as illustrated by his recent articles exploring meningiomas, brain tumor recurrence, and the blood-brain barrier. Dr. Hirayama's work employs advanced imaging techniques and investigates the implications of various treatments and biomarkers in the context of neurological diseases.

Recent Grants

Grant: Close

Telomere maintenance in meningiomas

Open Date: 2015-04-01

Close Date: 2018-03-31

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (1)

Yukio Ago

Professor

Hiroshima University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ryuichi Hirayama

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Ophthalmic Artery Feeders in Meningioma Reduce the Effectiveness of Transarterial Embolization With n-Butyl Cyanoacrylate

Automated volumetry of meningiomas in contrast-enhanced T1-Weighted MRI using deep learning

Association of Plasma Claudin-5 with Age and Alzheimer Disease

Safety and efficacy of an anti-claudin-5 monoclonal antibody to increase blood–brain barrier permeability for drug delivery to the brain in a non-human primate

A case of meningolacrimal artery aneurysm associated with meningioma

Determination of brain tumor recurrence using <sup>11</sup>C-methionine positron emission tomography after radiotherapy

Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas

Overview of the Premarketing and Postmarketing Requirements for Drugs Granted Japanese Conditional Marketing Approval

The Impact of 5-Year Tumor Doubling Time to Predict the Subsequent Long-Term Natural History of Asymptomatic Meningiomas

Primary central nervous system lymphoma of the bilateral Bochdalek's flower baskets: A case report

The Roadmap to Approval under Japan's Two-Track Regulatory System: Comparing Six Regenerative Medical Products

Collaborators (1)

Yukio Ago

Make your next move.